Project

Development of an ex vivo sputum model to evaluate antibacterial strategies for the eradiction of Pseudomonas aeruginosa chronic airway infection in cystic fibriosis patients.

Code
01T00209
Duration
01 August 2009 → 31 May 2010
Funding
Regional and community funding: Special Research Fund
Research disciplines
  • Natural sciences
    • Microbiology
    • Systems biology
  • Medical and health sciences
    • Endocrinology and metabolic diseases
    • Gynaecology and obstetrics
    • Immunology
    • Laboratory medicine
    • Microbiology
    • Endocrinology and metabolic diseases
    • Gynaecology and obstetrics
    • Immunology
    • Laboratory medicine
    • Microbiology
    • Nursing
    • Endocrinology and metabolic diseases
    • Gynaecology and obstetrics
    • Immunology
    • Laboratory medicine
    • Microbiology
Keywords
biofilm pseudomonas aeruginosa microbiology chronic infection cystic fibrosis
 
Project description

Current models to simulate chronic P. aeruginosa infection of the airways of cystic fibrosis patients are only realistic to a limited extent. A realistic model could be developed in a rather simple manner by treating sputum from P. aeruginosa infected patients by different antibacterial strategies, in combination with different mucolytic methods. The eradication success of the different strategies can then be compared by means of culture and quantitative PCR, whereby the latter enables the quantitation of the fastidious biofilm associated cells. This model is not only offers the most realistic simulation currently achievable, it also makes it possible to evaluate individualized treatments, because the infection status of every patient is different.